For: | Wachsmann J, Peng F. Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 221-231 [PMID: 26755872 DOI: 10.3748/wjg.v22.i1.221] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/221.htm |
Number | Citing Articles |
1 |
Zhili Liu, Huihan Ma, Zelin Lai. Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03425-9
|
2 |
Guilin Nie, Dingzhong Peng, Ningyuan Wen, Yaoqun Wang, Jiong Lu, Bei Li. Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1096351
|
3 |
Ran Chen, Haichao Luo, Qitian Chen, Changying Wang. Identification of a cuproptosis-related lncRNA prognostic signature in lung adenocarcinoma. Clinical and Translational Oncology 2023; 25(6): 1617 doi: 10.1007/s12094-022-03057-6
|
4 |
Xiaoqian Ma, Nuo Lin, Qing Yang, Peifei Liu, Haizhen Ding, Mengjiao Xu, Fangfang Ren, Zhiyang Shen, Ke Hu, Shanshan Meng, Hongmin Chen. Biodegradable copper-iodide clusters modulate mitochondrial function and suppress tumor growth under ultralow-dose X-ray irradiation. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-52278-6
|
5 |
Larica Pathaw, Themmila Khamrang, Arunkumar Kathiravan, Marappan Velusamy. Synthesis, crystal structure, bovine serum albumin binding studies of 1,2,4-triazine based copper(I) complexes. Journal of Molecular Structure 2020; 1207: 127821 doi: 10.1016/j.molstruc.2020.127821
|
6 |
Tânia S. Morais, Yann Jousseaume, M. Fátima M. Piedade, Catarina Roma-Rodrigues, Alexandra R. Fernandes, Fernanda Marques, Maria J. Villa de Brito, M. Helena Garcia. Important cytotoxic and cytostatic effects of new copper(i)–phosphane compounds with N,N, N,O and N,S bidentate ligands. Dalton Transactions 2018; 47(23): 7819 doi: 10.1039/C8DT01653D
|
7 |
Iurii A. Orlov, Tatiana P. Sankova, Alexey N. Skvortsov, Sergey A. Klotchenko, Elena I. Sakhenberg, Aleksandra A. Mekhova, Irina V. Kiseleva, Ekaterina Yu. Ilyechova, Ludmila V. Puchkova. Properties of recombinant extracellular N-terminal domain of human high-affinity copper transporter 1 (hNdCTR1) and its interactions with Cu(ii) and Ag(i) ions. Dalton Transactions 2023; 52(11): 3403 doi: 10.1039/D2DT04060C
|
8 |
Yicheng Jiang, Zhiyi Huo, Xiaole Qi, Tongmei Zuo, Zhenghong Wu. Copper-Induced Tumor Cell Death Mechanisms and Antitumor Theragnostic Applications of Copper Complexes. Nanomedicine 2022; 17(5): 303 doi: 10.2217/nnm-2021-0374
|
9 |
Aisheng Dong, Xinping Zhong, Yang Wang. Pedunculated Hepatocellular Carcinoma Mimicking Right Adrenal Tumor on FDG PET/CT. Clinical Nuclear Medicine 2018; 43(7): e242 doi: 10.1097/RLU.0000000000002096
|
10 |
Jun An, Zhiyong Liu, Qiong Liang, Yuhang Pan, Haifeng Li, Ruizhi Wang, Yi Jin. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma. Human Pathology 2017; 67: 146 doi: 10.1016/j.humpath.2017.07.008
|
11 |
Claudia A. Blindauer. Clinical and Translational Perspectives on WILSON DISEASE. 2019; : 85 doi: 10.1016/B978-0-12-810532-0.00010-0
|
12 |
Yuhang Pan, Zhiyong Liu, Zhiying Feng, Dayang Hui, Xiangqi Huang, Dayue Tong, Yi Jin. The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma. Tumor Biology 2017; 39(4): 101042831769623 doi: 10.1177/1010428317696230
|
13 |
Francesca P. Solari, J. Brad Case, Federico R. Vilaplana Grosso, Judith Bertran, Stacey Fox‐Alvarez, Roniel Cabrera. Laparoscopic ultrasound‐guided microwave ablation of hepatocellular carcinoma in a dog. Veterinary Surgery 2024; 53(8): 1495 doi: 10.1111/vsu.14163
|
14 |
Takashi Himoto, Tsutomu Masaki. Current Trends on the Involvement of Zinc, Copper, and Selenium in the Process of Hepatocarcinogenesis. Nutrients 2024; 16(4): 472 doi: 10.3390/nu16040472
|
15 |
Mohd Farhan, Mohammad Aatif, Sheikh Mumtaz Hadi, Aamir Ahmad. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2022; : 2559 doi: 10.1007/978-981-15-9411-3_179
|
16 |
Zixin Wu, Guishuai Lv, Fuxue Xing, Wei Xiang, Yue Ma, Qiyu Feng, Wen Yang, Hongyang Wang. Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials. Cancer Letters 2023; 571: 216348 doi: 10.1016/j.canlet.2023.216348
|
17 |
Bianca Gutfilen, Adriano Duatti. Editorial: In-vivo targeting of nuclear DNA with radioactive copper-64 ions. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1334294
|
18 |
Kristoffer Kjærgaard, Thomas Damgaard Sandahl, Kim Frisch, Karina Højrup Vase, Susanne Keiding, Hendrik Vilstrup, Peter Ott, Lars Christian Gormsen, Ole Lajord Munk. Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CT. EJNMMI Radiopharmacy and Chemistry 2020; 5(1) doi: 10.1186/s41181-020-00100-1
|
19 |
Xueying Zhao, Jin Chen, Shangqi Yin, Jingren Shi, Mei Zheng, Chaonan He, Huan Meng, Ying Han, Jinyu Han, Jingjing Guo, Zhengrong Yuan, Yajie Wang. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.992468
|
20 |
Ren-Cai Lu, Bo She, Wen-Tao Gao, Yun-Hai Ji, Dong-Dong Xu, Quan-Shi Wang, Shao-Bo Wang. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World Journal of Gastroenterology 2019; 25(32): 4682-4695 doi: 10.3748/wjg.v25.i32.4682
|
21 |
Yuhui Yun, Yun Wang, Ende Yang, Xin Jing. Cuproptosis-Related Gene – SLC31A1, FDX1 and ATP7B – Polymorphisms are Associated with Risk of Lung Cancer. Pharmacogenomics and Personalized Medicine 2022; : 733 doi: 10.2147/PGPM.S372824
|
22 |
Alessandra Boschi, Petra Martini, Emilija Janevik-Ivanovska, Adriano Duatti. The emerging role of copper-64 radiopharmaceuticals as cancer theranostics. Drug Discovery Today 2018; 23(8): 1489 doi: 10.1016/j.drudis.2018.04.002
|
23 |
Ze Yu, Rongtao Zhou, Yicheng Zhao, Yi Pan, Hao Liang, Jin‐San Zhang, Sheng Tai, Liang Jin, Chun‐Bo Teng. Blockage of SLC31A1‐dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Proliferation 2019; 52(2) doi: 10.1111/cpr.12568
|
24 |
Leyla Fouani, Sharleen V. Menezes, Mellow Paulson, Des R. Richardson, Zaklina Kovacevic. Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents. Pharmacological Research 2017; 115: 275 doi: 10.1016/j.phrs.2016.12.001
|
25 |
Thomas Damgaard Sandahl, Lars C. Gormsen, Kristoffer Kjærgaard, Mikkel Holm Vendelbo, Ditte Emilie Munk, Ole Lajord Munk, Dirk Bender, Susanne Keiding, Karina H. Vase, Kim Frisch, Hendrik Vilstrup, Peter Ott. The pathophysiology of Wilson’s disease visualized: A human 64Cu PET study. Hepatology 2022; 75(6): 1461 doi: 10.1002/hep.32238
|
26 |
Cailin C. Harro, Rebecca C. Smedley, John P. Buchweitz, Daniel K. Langlois. Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma. Journal of Veterinary Internal Medicine 2019; 33(5): 2193 doi: 10.1111/jvim.15619
|
27 |
Xiaoyan Li, Jinping Wang, Zongliang Guo, Yong Ma, Dawei Xu, Daguang Fan, Peng Dai, Yifan Chen, Qiongwen Liu, Jinke Jiao, Jinhan Fan, Ningxue Wu, Xin Li, Guoyin Li. Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis. Aging 2023; 15(24): 15084 doi: 10.18632/aging.205334
|
28 |
Hongjin Wang, Nian Wang, Ze Tang, Qiuyu Liu, Shiyu Nie, Wu Tao. An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis. Hereditas 2023; 160(1) doi: 10.1186/s41065-023-00288-7
|
29 |
Yaqing Su, Xiaomei Zhang, Shaoqiang Li, Wei Xie, Jianping Guo. Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis. Molecular Cancer Research 2022; 20(9): 1339 doi: 10.1158/1541-7786.MCR-22-0056
|
30 |
Anne-Sophie Navarro, Thomas Le Bihan, Patricia Le Saëc, Nathalie Le Bris, Clément Bailly, Catherine Saï-Maurel, Mickaël Bourgeois, Michel Chérel, Raphaël Tripier, Alain Faivre-Chauvet. TE1PA as Innovating Chelator for 64Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model. Bioconjugate Chemistry 2019; 30(9): 2393 doi: 10.1021/acs.bioconjchem.9b00510
|
31 |
Victor P. Bondanese, Aline Lamboux, Melanie Simon, Jérôme E. Lafont, Emmanuelle Albalat, Sylvain Pichat, Jean-Marc Vanacker, Philippe Telouk, Vincent Balter, Philippe Oger, Francis Albarède. Hypoxia induces copper stable isotope fractionation in hepatocellular carcinoma, in a HIF-independent manner. Metallomics 2016; 8(11): 1177 doi: 10.1039/C6MT00102E
|
32 |
Xin Lu, Zhiyuan Chen, Wenting Mi, Jianming Zheng, Yubin Liu. MARK1 suppress malignant progression of hepatocellular carcinoma and improves sorafenib resistance through negatively regulating POTEE. Open Medicine 2024; 19(1) doi: 10.1515/med-2024-1060
|
33 |
Julia Greiser, Wolfgang Weigand, Martin Freesmeyer. Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver. Pharmaceuticals 2019; 12(3): 137 doi: 10.3390/ph12030137
|
34 |
Xu Wang, Mingzhi Han, Songyu Chen, Yanfei Sun, Ruirong Tan, Bin Huang. The copper-associated protein STEAP2 correlated with glioma prognosis and immune infiltration. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.944682
|
35 |
Lei Jiang, Yingfeng Tu, Xiang Hu, Ande Bao, Hao Chen, Xiaowei Ma, Tim Doyle, Hongcheng Shi, Zhen Cheng. Pilot Study of 64Cu(I) for PET Imaging of Melanoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02691-3
|
36 |
Lei Jiang, Dongli Song, Hao Chen, Ao Zhang, Huoqiang Wang, Zhen Cheng. Pilot Study of 64CuCl2 for PET Imaging of Inflammation. Molecules 2018; 23(2): 502 doi: 10.3390/molecules23020502
|
37 |
Cristiana Porcu, Laura Antonucci, Barbara Barbaro, Barbara Illi, Sergio Nasi, Maurizio Martini, Anna Licata, Luca Miele, Antonio Grieco, Clara Balsano. Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma. Oncotarget 2018; 9(10): 9325 doi: 10.18632/oncotarget.24282
|
38 |
Tao Liu, Yali Liu, Feiyu Zhang, Yanhang Gao. Copper homeostasis dysregulation promoting cell damage and the association with liver diseases. Chinese Medical Journal 2023; doi: 10.1097/CM9.0000000000002697
|
39 |
Xin Li, Yongliang Zhong, Chunyan Zhao. Trypsin Binding with Copper Ions Scavenges Superoxide: Molecular Dynamics-Based Mechanism Investigation. International Journal of Environmental Research and Public Health 2018; 15(1): 139 doi: 10.3390/ijerph15010139
|
40 |
Gulshan R. Walke, Sharon Ruthstein. Does the ATSM-Cu(II) Biomarker Integrate into the Human Cellular Copper Cycle?. ACS Omega 2019; 4(7): 12278 doi: 10.1021/acsomega.9b01748
|
41 |
Laura Gartmann, Thomas Wex, Kurt Grüngreiff, Dirk Reinhold, Thomas Kalinski, Peter Malfertheiner, Kerstin Schütte. Expression of zinc transporters ZIP4, ZIP14 and ZnT9 in hepatic carcinogenesis—An immunohistochemical study. Journal of Trace Elements in Medicine and Biology 2018; 49: 35 doi: 10.1016/j.jtemb.2018.04.034
|
42 |
Mohd Farhan, Mohammad Aatif, Sheikh Mumtaz Hadi, Aamir Ahmad. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2021; : 1 doi: 10.1007/978-981-15-4501-6_179-1
|
43 |
Zhili Liu, Yuzhe Sun, Hefu Zhen, Chao Nie, Li-Ping Kang. Network Pharmacology Integrated with Transcriptomics Deciphered the Potential Mechanism of Codonopsis pilosula against Hepatocellular Carcinoma. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1340194
|
44 |
Haseeb Zubair, Shafquat Azim, Husain Khan, Mohammad Ullah, Daocheng Wu, Ajay Singh, Sheikh Hadi, Aamir Ahmad. Mobilization of Intracellular Copper by Gossypol and Apogossypolone Leads to Reactive Oxygen Species-Mediated Cell Death: Putative Anticancer Mechanism. International Journal of Molecular Sciences 2016; 17(6): 973 doi: 10.3390/ijms17060973
|